A compound having GPR52 agonist activity or a salt thereof is provided. The compound can be provided as a preventive / therapeutic agent for schizophrenia or the like. The compound is represented by the following formula (Ia): wherein A represents -CONR2- or -NR2CO-, R2 represents a hydrogen atom or the like, B represents a hydrogen atom or the like, a ring CyI represents a six-membered aromatic ring which may have one or more substituents in addition to a group represented by -A-B, a ring Cy2 represents a six-membered ring which may be substituted with a halogen atom or the like, a ring Cy3 represents a five- or six-membered ring which may have one or more substituents; X represents C1-2 alkylene or the like, m represents an integer of 0 to 2, and a ring Cy4 represents a six-membered aromatic ring which may have one or more substituents.
AMIDE COMPOUND
申请人:Setoh Masaki
公开号:US20100041891A1
公开(公告)日:2010-02-18
A compound having GPR52 agonist activity or a salt thereof is provided.
The compound can be provided as a preventive/therapeutic agent for schizophrenia or the like. The compound is represented by the following formula:
wherein
A represents —CONR
a
— or —NR
a
CO—,
R
a
represents a hydrogen atom or the like,
B represents a hydrogen atom or the like,
a ring Cy1 represents a six-membered aromatic ring which may have one or more substituents in addition to a group represented by -A-B,
a ring Cy2 represents a six-membered ring which may be substituted with a halogen atom or the like,
a ring Cy3 represents a five- or six-membered ring which may have one or more substituents;
X represents C
1-2
alkylene or the like,
m represents an integer of 0 to 2, and
a ring Cy4 represents a six-membered aromatic ring which may have one or more substituents.